3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
10
Colonic Neoplasms
9
Prostatic Neoplasms
8
Colorectal Neoplasms
6
Neoplasms
5
Multiple Myeloma
4
Uterine Cervical Neoplasms
3
Stomach Neoplasms
3
Smoldering Multiple Myeloma
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Monoclonal Gammopathy of Undetermined Significance
3
Lung Neoplasms
3
Adenomatous Polyposis Coli
3
Uterine Cervical Dysplasia
2
Radiodermatitis
2
Pain
2
Esophageal Neoplasms
2
Breast Carcinoma In Situ
2
cyclopia sequence
1
Uterine Neoplasms
1
Tuberous Sclerosis
1
Thrombocythemia, Essential
1
Stomatitis
1
Sezary Syndrome
1
Seizures
1
Psychological Well-Being
1
Prostate Cancer Metastatic Castration Resistant
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Levetiracetam
6
Cannabidiol
4
perampanel
2
Standard of Care
2
Everolimus
2
enzalutamide
1
Vigabatrin
1
Tranexamic Acid
1
Temozolomide
1
Sodium Chloride
1
Saline Solution
1
Pregabalin
1
Medical Marijuana
1
Magnesium Sulfate
1
Drug Therapy
1
Curcumin
1
Cholecalciferol
1
Aspirin
1
Anticonvulsants
1
Anastrozole
1
Airway Extubation
1
2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Seizures
×
Curcumin
×
Clear all
NCT03254680
2018-04-30
Turmeric as Treatment in Epilepsy
NYU Langone Health
Phase NA
Withdrawn